Steven Cook Sells 2,600 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 2,600 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $19.02, for a total value of $49,452.00. Following the sale, the chief financial officer directly owned 166,659 shares in the company, valued at approximately $3,169,854.18. This trade represents a 1.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Omada Health Trading Up 10.5%

Shares of NASDAQ:OMDA opened at $20.89 on Friday. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The company has a market capitalization of $1.24 billion and a PE ratio of -77.37. The business has a 50 day moving average of $16.51 and a two-hundred day moving average of $14.85.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The business had revenue of $78.05 million for the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. Equities research analysts predict that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently commented on OMDA. Needham & Company LLC restated a “buy” rating and set a $28.00 price target on shares of Omada Health in a research report on Friday, May 8th. Morgan Stanley reiterated an “overweight” rating and issued a $30.00 price objective on shares of Omada Health in a research report on Monday, June 22nd. The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Barclays lifted their price target on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Finally, JPMorgan Chase & Co. reduced their price target on Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a report on Thursday, March 12th. Ten research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Institutional Trading of Omada Health

A number of institutional investors have recently made changes to their positions in the company. Perceptive Advisors LLC purchased a new stake in shares of Omada Health during the second quarter worth approximately $44,402,000. Millennium Management LLC boosted its stake in Omada Health by 1,195.0% during the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after purchasing an additional 2,096,705 shares during the last quarter. Loomis Sayles & Co. L P boosted its stake in Omada Health by 23.0% during the 4th quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock worth $29,283,000 after purchasing an additional 346,588 shares during the last quarter. Divisadero Street Capital Management LP purchased a new stake in shares of Omada Health during the third quarter worth $30,510,000. Finally, Jefferies Financial Group Inc. acquired a new stake in shares of Omada Health in the fourth quarter valued at about $16,948,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.